Cryo-Cell International Inc. | Cash Flow
Fiscal year is December-November. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
27.40
553.60
8,106.30
1,320.80
2,315.10
854.80
Depreciation, Depletion & Amortization
394.50
377.00
241.20
286.70
230.00
317.30
Other Funds
-
-
-
3,400.00
-
1,062.20
Funds from Operations
2,118.80
3,026.80
2,983.50
3,445.80
2,944.50
2,903.20
Changes in Working Capital
1,296.80
1,472.00
1,867.90
1,542.20
2,773.70
2,430.20
Net Operating Cash Flow
822.00
1,554.80
4,851.50
4,988.00
5,718.20
5,333.30
Capital Expenditures
397.30
120.50
483.90
343.00
98.30
Purchase/Sale of Investments
61.90
252.30
235.30
231.10
191.40
Net Investing Cash Flow
1,149.50
391.20
719.30
574.10
93.00
Issuance/Reduction of Debt, Net
-
-
123.60
9,274.30
2,650.00
Net Financing Cash Flow
723.70
2,591.90
3,259.20
5,270.50
3,031.90
Net Change in Cash
1,247.80
645.90
872.90
856.60
2,779.30
Free Cash Flow
472.20
1,434.30
4,743.00
4,645.00
5,619.80
Deferred Taxes & Investment Tax Credit
-
-
7,369.50
1,911.80
774.80
2,378.50
Other Sources
1,608.70
764.00
-
-
-
Change in Capital Stock
723.70
2,591.90
3,135.60
11,144.90
381.90
About Cryo-Cell International
View Profile
